Covid-19 rapid antigen tests are seeing massive revenue growth. The popularity of these tests can be attributed to their ease ...

Abbott ABT is facing a challenging business environment globally. Unfavorable foreign exchange impact continues to impede ...

The ABBOTT PRISM system is intended for in vitro diagnostic use only. A high throughput, highly automated test system for blood screening: The ABBOTT PRISM is a fully automated, high-volume blood ...

Ausria, a radioimmunoassay test to detect serum hepatitis, was launched in 1972 and marked the beginning of Abbott's immunodiagnostics business. A year later, the Abbott Diagnostics Division was ...

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received clearance for the use of rapid-acting insulin with its ...

New survey from Abbott finds epidemiologists believe viral and mosquito-borne pathogens are priority concerns for disease outbreaks: Abbott Park, Illinois Thursday, September 19, ...

Blood sugar tracking is officially general-wellness territory. Abbott announced Thursday that its prescription-free continuous glucose monitor, Lingo, is now available for sale in the US.

Abbott Laboratories' diabetes care segment recently added new products to its lineup. It should remain one of the company's key growth drivers over the long run. There are other good reasons to ...

Report with market evolution powered by AI- The global hepatitis b and c diagnostics market size is estimated to grow by USD ...

Abbott’s ABT diversified business portfolio is well-positioned to drive continued momentum in 2024. However, Abbott is facing a challenging business environment globally. ABT currently carries a ...